Incyte (INCY) has been quietly outperforming the broader biotech space this year, with the stock up about 46% over the past year and more than 40% year to date, drawing fresh attention. See our latest ...

Incyte (INCY) shares soared 5.5% in the last trading session to close at $102.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Baker Brothers’ Q3 2025 13F portfolio rose to $13.84B, with high concentration in BeOne Medicines, Incyte, Madrigal Pharma, Insmed, and ACADIA Pharma. INCY, now ~19% of the portfolio, saw a marginal ...

Incyte Corporation (NASDAQ:INCY) Q2 2025 Earnings Call Transcript July 29, 2025 Incyte Corporation beats earnings expectations. Reported EPS is $2.04, expectations were $1.39. Operator: Greetings, and ...

Investing.com - RBC Capital has reiterated its Sector Perform rating and $84.00 price target on Incyte (NASDAQ:INCY) following a visit to the company’s headquarters. This target sits notably below the ...

A collection of films following Peter Parker as he navigates adolescence while taking on the responsibilities of being Spider-Man in a world filled with superheroes. As Peter faces increasingly ...

From the creators of ‘Generation Barney’, ‘Generation Gilmore Girls’ revisits the popular TV series and asks why it still resonates 25 years later. We learn how it shaped some of the actors who worked ...